Clinical Trials Directory

Trials / Conditions / Metastatic Nasopharyngeal Carcinoma

Metastatic Nasopharyngeal Carcinoma

14 registered clinical trials studyying Metastatic Nasopharyngeal Carcinoma — 6 currently recruiting.

StatusTrialSponsorPhase
RecruitingEGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma
NCT06802835
Sun Yat-Sen University Cancer CenterPhase 1 / Phase 2
RecruitingTesting the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurre
NCT06029270
National Cancer Institute (NCI)Phase 2
Not Yet RecruitingStop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma
NCT06331845
Fujian Cancer HospitalPhase 2
RecruitingTesting Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Me
NCT05904080
National Cancer Institute (NCI)Phase 2
RecruitingMetastatic Nasopharyngeal Carcinoma
NCT06886347
Chen XiaozhongPhase 1
Not Yet RecruitingCapecitabine Plus Toripalimab Maintenance Therapy in Metastatic Nasopharyngeal Carcinoma After First-line Trea
NCT05484375
Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityPhase 2
UnknownEfficacy and Safety of Sintilimab Plus Bevacizumab in Metastatic Nasopharyngeal Carcinoma After Failure of Pla
NCT04872582
XIANG YANQUNPhase 2
TerminatedTesting the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Ci
NCT04458909
National Cancer Institute (NCI)Phase 3
WithdrawnDurvalumab and Epacadostat for Treatment of Unresectable, Recurrent, or Metastatic Epstein-Barr Virus Positive
NCT04231864
Alain AlgaziPhase 2
UnknownA Trial of LONSURF in Recurrent/Metastatic Nasopharyngeal Carcinoma
NCT04627961
National University Hospital, SingaporePhase 2
UnknownToripalimab and Gemcitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma.
NCT04405622
Sun Yat-sen UniversityPhase 2
UnknownApatinib and Camrelizumab in Recurrent or Metastatic Nasopharyngeal Carcinoma With First-line Treatment Failur
NCT04586088
Sun Yat-sen UniversityPhase 2
UnknownStudy of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma
NCT03639467
Chinese Academy of Medical SciencesPhase 1 / Phase 2
CompletedFamitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)
NCT01392235
Jiangsu HengRui Medicine Co., Ltd.Phase 2